Cell-based therapies have become integral to the routine clinical management of hematologic malignancies. Tumor-infiltrating lymphocyte (TIL) therapy has demonstrated efficacy in immunogenic solid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results